IRIS UniCatt

Masucci, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.474
EU - Europa 3.601
AS - Asia 3.560
SA - Sud America 663
AF - Africa 113
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.436
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.319
SG - Singapore 1.623
DE - Germania 905
CN - Cina 786
IT - Italia 745
SE - Svezia 526
BR - Brasile 523
VN - Vietnam 336
FR - Francia 333
PL - Polonia 258
IE - Irlanda 151
GB - Regno Unito 146
IN - India 131
HK - Hong Kong 128
FI - Finlandia 119
UA - Ucraina 114
ID - Indonesia 97
JP - Giappone 86
CA - Canada 80
BD - Bangladesh 72
RU - Federazione Russa 63
AR - Argentina 51
NL - Olanda 50
TR - Turchia 47
AT - Austria 44
MX - Messico 42
KR - Corea 39
IQ - Iraq 33
ES - Italia 31
ZA - Sudafrica 28
BE - Belgio 26
EC - Ecuador 20
MA - Marocco 20
SA - Arabia Saudita 20
AU - Australia 18
CZ - Repubblica Ceca 18
PH - Filippine 17
CH - Svizzera 16
VE - Venezuela 16
LT - Lituania 14
PK - Pakistan 14
CL - Cile 13
IR - Iran 13
CO - Colombia 12
JO - Giordania 11
NP - Nepal 11
NG - Nigeria 10
TW - Taiwan 10
AZ - Azerbaigian 9
MY - Malesia 9
TH - Thailandia 9
TN - Tunisia 9
BO - Bolivia 8
EG - Egitto 8
PE - Perù 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CY - Cipro 7
GR - Grecia 7
IL - Israele 7
JM - Giamaica 7
CI - Costa d'Avorio 6
DZ - Algeria 6
KE - Kenya 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
HR - Croazia 5
HU - Ungheria 5
KZ - Kazakistan 5
PY - Paraguay 5
BB - Barbados 4
GH - Ghana 4
HN - Honduras 4
LB - Libano 4
NO - Norvegia 4
PA - Panama 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
GT - Guatemala 3
KG - Kirghizistan 3
MD - Moldavia 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
LV - Lettonia 2
MM - Myanmar 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
SI - Slovenia 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 12.418
Salva come PNG Salva come JPEG
Città #
Singapore 900
Ashburn 464
San Jose 455
Chandler 442
Warsaw 240
Beijing 160
Dublin 149
Rome 142
New York 123
Hong Kong 117
Ann Arbor 116
Los Angeles 112
Ho Chi Minh City 105
Milan 92
Hanoi 85
Jakarta 85
Lauterbourg 85
Fairfield 83
Hefei 83
Jacksonville 83
Tokyo 80
Chicago 73
Wilmington 70
Woodbridge 70
The Dalles 65
Council Bluffs 63
Boston 62
Frankfurt am Main 62
San Mateo 61
Munich 58
Houston 55
Dearborn 54
Marseille 54
São Paulo 48
Nanjing 47
St Louis 47
Helsinki 44
Princeton 43
Cattolica 41
Dallas 40
Moscow 40
Seattle 37
Seoul 37
Boardman 31
Santa Clara 31
Redwood City 30
Turku 30
London 27
Stockholm 27
Nuremberg 26
Izmir 25
Pune 25
Buffalo 24
Kent 23
Nürnberg 22
Orem 22
Vienna 22
Hangzhou 21
Johannesburg 21
Lawrence 21
Paris 21
Atlanta 20
Brooklyn 20
Brussels 20
Cambridge 20
Lappeenranta 20
Denver 19
Montreal 19
San Francisco 19
Zhengzhou 19
Da Nang 18
Redmond 18
Baghdad 17
Falkenstein 17
North Bergen 17
Poplar 17
Düsseldorf 16
Nanchang 16
Tianjin 16
Augusta 15
Dhaka 15
Florence 15
Toronto 15
Washington 15
Mexico City 14
Phoenix 14
Rio de Janeiro 14
Shanghai 14
Falls Church 13
Kunming 13
Guangzhou 12
Hyderabad 12
Melbourne 12
Zurich 12
Amman 11
Charlotte 11
Hebei 11
Manchester 11
Mountain View 11
Norwalk 11
Totale 6.420
Salva come PNG Salva come JPEG
Nome #
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 486
Consorzio di probiotici / Probiotic mixture 373
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 277
Whole-genome sequencing reveals host factors underlying critical COVID-19 223
The role of diet on gut microbiota composition 216
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 210
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 209
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 198
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 181
The effect of different antibiotic regimens on bacterial resistance: a systematic review 181
Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases 176
Polymerase chain reaction-reverse cross-blot hybridization assay in the diagnosis of sporotrichoid Mycobacterium marinum infection 172
Entamoeba dispar: A Rare Case of Enteritis in a Patient Living in a Nonendemic Area 172
Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice 166
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm 165
Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection. 165
An explainable model of host genetic interactions linked to COVID-19 severity 164
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 164
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 163
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 163
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss 162
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 160
European consensus conference on faecal microbiota transplantation in clinical practice 158
Intestinal Parasitic Infections in Internationally Adopted Children: A 10-Year Retrospective Study 157
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 155
In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates. 154
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 151
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 149
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial 149
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 146
A literature review of metagenomics and culturomics of the peri-implant microbiome: Current evidence and future perspectives 146
Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates 144
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: a pre-post analysis in a Third Level Referral Center 144
A patient with acute myeloid leukemia and a solid mass in the colon. 142
Multiple malaria infection in a pregnant woman from Nigeria: detection by multiplex PCR 139
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 138
International consensus statement on microbiome testing in clinical practice 137
Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study 137
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 136
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 136
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 132
Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016 132
Reply to Seligman 131
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 130
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 128
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 127
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection 125
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 124
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 120
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 114
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 113
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 113
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 112
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 112
Genetic mechanisms of critical illness in COVID-19 112
Fecal microbiota transplantation: What’s new? 111
Mapping the human genetic architecture of COVID-19 111
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 110
How the gut parasitome affects human health 109
Characterizing peri-implant and sub-gingival microbiota through culturomics. First isolation of some species in the oral cavity. A pilot study 106
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 106
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 105
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 105
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 105
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 104
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 103
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies 102
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 102
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 100
Laboratory handling practice for faecal microbiota transplantation 99
Conjonctival papilloma and human papillomavirus: identification of HPV types by PCR. 98
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 96
SARS-CoV-2 vaccines and donor recruitment for FMT 96
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 93
Laboratory handling practice for faecal microbiota transplantation 93
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 91
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 91
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes 90
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 86
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 86
The Italian national faecal microbiota transplantation program: A coordinated effort against Clostridioides difficile infection 85
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 80
comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis 79
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone 78
PCR-reverse cross blot hybridization assay as an useful diagnostic tool in a case of Mycobacterium marinum sporotrichoid infection 75
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 70
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 70
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions 69
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel 69
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 68
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 67
Culturomic and quantitative real-time-polymerase chain reaction analyses for early contamination of abutments with different surfaces: A randomized clinical trial 64
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel 56
Clinical and molecular characterization of COVID-19 hospitalized patients 52
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 51
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 42
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 29
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial 14
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 8
Informed Therapeutic Microbiome Modulation for Post-Infectious Irritable Bowel Syndrome: Pilot Experience of a Microbiome Clinic 3
Totale 12.616
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022611 69 27 18 29 35 27 10 68 34 34 155 105
2022/20231.475 195 176 90 155 104 165 89 127 194 95 53 32
2023/2024943 59 225 39 66 44 146 77 25 19 50 93 100
2024/20251.977 39 70 135 110 156 72 97 79 260 228 402 329
2025/20265.558 710 151 306 593 908 620 896 224 341 404 244 161
Totale 12.618